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Abstract
The Fe(II)- and 2-oxoglutarate (2OG)-dependent dioxygenase AlkB from E. coli is a demethylase which repairs alkyl lesions in
DNA, as well as RNA, through a direct reversal mechanism. Humans possess nine AlkB homologs (ALKBH1-8 and FTO).
ALKBH2 and ALKBH3 display demethylase activities corresponding to that of AlkB, and both ALKBH8 and FTO are RNA
modification enzymes. The biochemical functions of the rest of the homologs are still unknown. To increase our knowledge
on the functions of ALKBH4 and ALKBH7 we have here performed yeast two-hybrid screens to identify interaction partners
of the two proteins. While no high-confidence hits were detected in the case of ALKBH7, several proteins associated with
chromatin and/or involved in transcription were found to interact with ALKBH4. For all interaction partners, the regions
mediating binding to ALKBH4 comprised domains previously reported to be involved in interaction with DNA or chromatin.
Furthermore, some of these partners showed nuclear co-localization with ALKBH4. However, the global gene expression
pattern was only marginally altered upon ALKBH4 over-expression, and larger effects were observed in the case of ALKBH7.
Although the molecular function of both proteins remains to be revealed, our findings suggest a role for ALKBH4 in
regulation of gene expression or chromatin state.
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Introduction
The superfamily of Fe(II)- and 2-oxoglutarate (2OG)-dependent
dioxygenases comprise enzymes which catalyze oxidation reac-
tions in a diverse set of biological processes such as post-
translational modification of collagen, the hypoxic response
pathway and epigenetic regulation [1–6]. These proteins are
characterized by their catalytic requirement for ferrous iron as well
as the co-substrate 2OG. The primary oxidation reactions they
catalyze are coupled to decarboxylation of 2OG, yielding
succinate and CO2. The E. coli AlkB protein [7] is an Fe(II)/
2OG dioxygenase involved in DNA and RNA repair, and is
induced as part of the adaptive response to alkylation damage.
Targeting alkyl lesions at N1-position in purines and N3-position
in pyrimidines, AlkB directly reverses the base damage by an
oxidative mechanism that involves hydroxylation of the alkyl
group, which is consequently destabilized and spontaneously
released [8,9]. The repertoire of AlkB substrates has extended
from the originally identified simple methyl lesions 1-methylade-
nine (1-meA) and 3-methylcytosine (1-meC), to also comprise
larger adducts, such as ethyl, propyl and etheno groups [10–13], as
well as methylated RNA [14].
In mammals, nine AlkB homologs have been reported;
ALKBH1-8, as well as the fat mass and obesity protein (FTO)
[15,16]. ALKBH2 and ALKBH3 have similar activities as AlkB,
ALKBH2 being most active on dsDNA, while ALKBH3
preferentially demethylates ssDNA and ssRNA [14]. FTO has
also, with its weak activity towards 3-methylthymine (3-meT) in
ssDNA and 3-methyluracil (3-meU) in ssRNA, been implicated in
nucleic acid repair [16,17], but the recent identification of N6-
methyladenosine (6-meA) in ssRNA as a preferred substrate
indicates a role for FTO in regulating mRNA modification [18].
With the recent demonstration of ALKBH8 being involved in
hypermodification of tRNA wobble uridines [19–22], the function
of the mammalian ALKBH proteins was definitely shown to
extend beyond nucleic acid repair. ALKBH1, the mammalian
homolog with highest similarity to AlkB, has also been reported to
display DNA repair activity [23]. However, the significance of this
activity, which has not been confirmed by others, is unclear, and
there are indications rather pointing towards a function for
ALKBH1 in epigenetic gene regulation, potentially through
histone demethylation [24,25], thereby supporting the suggestion
that some of the human ALKBHs are involved in protein
demethylation [26,27]. In line with this, the S. pombe AlkB homolog
Ofd2 was recently reported to interact with histones [28]. While 2-
oxoglutarate decarboxylase activity has been demonstrated for
ALKBH4 and ALKBH5 [29,30], their primary substrates and
biological functions still remain, together with those of ALKBH1,
ALKBH6 and ALKBH7, to be revealed.
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The present study focuses on the human ALKBH4 and
ALKBH7 proteins. Through yeast two-hybrid screening, we show
binding of ALKBH4 to several proteins with associations to
chromatin regulation and transcription. Furthermore, for a selec-
tion of these, we demonstrate nuclear co-localization with
ALKBH4. However, as revealed through gene expression pro-
filing, ALKBH4 over-expression marginally affects the expression
pattern in HEK293 cells, while over-expression of ALKBH7
influences biological pathways such as cell cycle, DNA repair and
spermatogenesis, and positively regulates a number of genes
involved in meiotic recombination. Thus, this work provides novel
insight into the biological function of mammalian AlkB homologs
for which no biochemical activity has yet been reported.
Results
Yeast Two-hybrid Screens Identified ALKBH4 Binding
Partners Involved in Transcription
To improve our knowledge on ALKBH4 and ALKBH7
function, we searched to identify interaction partners of these
proteins through yeast two-hybrid (Y2H) screens. Screens were
performed using ALKBH4 as bait against two different human
libraries, one from placenta and another from fetal brain
(Hybrigenics, France). ALKBH7 was used as bait to screen the
fetal brain library. While we did not obtain any hits considered
highly confident in the ALKBH7 screen, a total of ten such hits
were detected in the two screens concerning ALKBH4 (Table 1).
Notably, five of these proteins have been associated with
transcription and chromatin modification, suggesting a function
of ALKBH4 in gene regulation. Of these, the transcriptional co-
activator and histone acetyltransferase (HAT) p300 [31] was the
only protein identified in both screens and, of note, the highly
similar p300 paralog CBP was not detected in any of them. The
homeotic transcription factor ATBF1 [32,33] and the tissue
specific heat-shock transcription factor HSF4 [34,35] were
identified as ALKBH4 partners exclusively in the placenta screen.
The proteins AF9 and ENL, which have similar biological
functions and display very high sequence homology (56% identity
throughout the entire sequence) [36] were identified in the
placenta and brain screens, respectively. The specific functions of
AF9 and ENL are currently unknown, but they have both been
associated with histone modification and transcriptional elonga-
tion [37–39].
To further investigate whether the observed interactions are
dependent on the enzymatic activity of ALKBH4, an enzymat-
ically inactive mutant (ALKBH4H169A/D171A) was used as bait in
a Y2H screen against the placenta library. Notably, this screen
retrieved a very similar set of proteins as the screen performed with
wild-type ALKBH4 (Table 1), indicating that the observed
interactions can occur independently of the oxygenase activity of
ALKBH4.
ALKBH4 Binding is Mediated by Chromatin-associated
Domains
The clones identified in the Y2H screens usually represented
non-full-length fragments of the interactants. The overlapping
sequences present in all clones representing the same partner
protein define the part of the protein that is responsible for the
interaction, the so-called selected interaction domain (SID). A
schematic representation of the transcription/chromatin-related
high confidence hits, depicting the SID involved in the interaction
with ALKBH4, is shown in Figure 1. Interestingly, for all five
proteins the SID encompassed only a limited region, and in all
cases this region included annotated domains reported to interact
with DNA and/or chromatin. For both AF9 and ENL, the
ALKBH4-interacting part mapped to the chromatin-associated
YEATS domain, while the portion of ATBF1 that binds ALKBH4
was shown to encompass two of the numerous C2H2-type zinc
fingers found in this protein. Moreover, we found the interaction
between ALKBH4 and HSF4 to be mediated through the amino-
terminal DNA binding domain (DBD) of the latter. Finally, the
region of p300 mediating the ALKBH4-interaction covered both
the bromodomain and plant homeodomain (PHD).
Since this region is adjacent to the HAT domain and since
bromo domain are known to bind to acetylated proteins, we
considered the possibility that ALKBH4 is acetylated by p300. To
address this issue, we used an anti-FLAG antibody to immuno-
precipitate FLAG-ALKBH4 from cell extracts containing over-
expressed p300 as well as FLAG-ALKBH4. However, no in vivo
ALKBH4 acetylation was detected (data not shown).
ALKBH4 Co-localizes with the Transcriptional Proteins
AF9, ENL and p300 in the Nucleoplasm and Nucleoli
We have made extensive efforts to verify the interactions that
were observed in the Y2H screen by independent methods, such as
pull-down experiments with recombinant GST-tagged proteins
and co-immunoprecipitation of tagged, co-expressed proteins from
cell lysates (experimental outlines can be found in the Materials
and Methods section). However, none of these efforts were
successful with respect to robust verification, possibly because the
interactions are transient and of low affinity. Nonetheless, given
the striking overrepresentation of DNA/chromatin binding
moieties of transcription-associated proteins among the interac-
tions, we still considered it likely that the corresponding
interactions are biologically relevant and occurring in mammalian
cells in vivo. To investigate this, the chromatin-related proteins that
were detected in both screens, AF9, ENL and p300, were selected
for co-localization studies with ALKBH4. HeLa cells were
transiently co-transfected with a plasmid encoding ALKBH4
fused to either Enhanced Cyan Fluorescent Protein (ALKBH4-
ECFP) or Enhanced Yellow Fluorescent Protein (ALKBH4-EYFP)
in combination with plasmids encoding EYFP/ECFP-fusions of
the selected partner proteins or truncations of these, and
localization patterns were analyzed by confocal microscopy. First,
we determined the subcellular localization of ALKBH4
(ALKBH4-EYFP) alone, which, consistent with a previous report
[40], was found to be localized both in the nucleus and the
cytoplasm, with similarly strong signals detected in the two
compartments (Figure 2A).
Co-localization with the AF9/ENL YEATS
domain. ALKBH4 showed nuclear co-localization with both
AF9 and ENL in which partial overlap in distinct spots in
nucleoplasm and nucleoli was observed for both proteins
(Figure 2B and 2C and data not shown). In order to address the
significance of the YEATS domain for these presumable
interactions, we examined the co-localization patterns of
ALKBH4 with two truncated ENL versions, which expressed
either the YEATS domain (EYFP-ENLYEATS) or the C-terminal
part (ENLC-EYFP). A co-localization pattern similar to that of full-
length ENL was obtained for the YEATS only version (Figure 2D).
However, deletion of the YEATS domain strongly reduced the co-
localization of ENL with ALKBH4 in nucleoli (Figure 2E). This
supports the results from the Y2H screens, strengthening the
indication of an interaction between ALKBH4 and AF9/ENL,
with the YEATS domain of latter being important for mediating
the interaction.
Co-localization with the bromodomain and PHD finger of
p300. In our Y2H screens, the p300 clones identified to bind
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ALKBH4 all encompassed both the bromodomain and PHD
finger, a protein domain combination that has been shown to
compose a functional protein moiety [41]. Thus, in order to
determine if p300 co-localizes with ALKBH4, we decided to use
an EYFP-tagged fragment of p300 covering the region of the
bromodomain and PHD only (aa 1039–1285, EYFP-p300BP),
instead of the full-length protein. Indeed, similar to what was
observed for AF9 and ENL, p300BP co-localized with ALKBH4 in
spots in nucleoli (Figure 2F). A similar nuclear localization pattern
and nucleolar presence has been previously reported for over-
expressed, full-length p300 [42]. Our results thus indicate an
interaction between ALKBH4 and p300BP. However, the in-
Table 1. High confidencea ALKBH4 interacting proteins identified by the yeast two-hybrid system.
Cellular process Gene Length (aa) SIDb
Domain(s)
encompassed by SID Screen
Fetal brain Placenta Placenta (ALKBH4H169A/D171A)
Transcription ATBF1 3703 1545–1626 C2H2 zinc fingers 2 + +
AF9 568 10–151 YEATS + 2 2
ENL 559 4–151 YEATS 2 + (+)c
HSF4 462 1–93 DBD 2 + +
p300 2414 1054–1352 Bromodomain, PHD + + +
Other TES 421 1–375 PET, LIM1–2 2 + +
EIF3C 914 749–882 PCI +d + 2
MTMR6 621 251–539 PTP + (+)c 2
PSMA6 246 11–232 Proteasome + 2 2
GID: 13396337 242 13–66 Transmembrane domain + 2 2
aPBS (predicted biological score) of A or B. PBS (calculated according to [75]) represents the probability of an interaction to be non-specific, and refers to an e-value with
defined thresholds to rank the results in the high-to-low confidence categories A–D.
bSID (selected interaction domain) refers to the amino acid region shared by all prey fragments matching the same reference protein,
c(+) Low confidence hit (PBS D),
dEIF3CL. Grey shade, transcription related interactants. YEATS, Yaf9 ENL AF9 TAF14 Sas5; DBD, DNA binding domain; PHD, plant homeodomain; PET, Prickle Espinas
Testin; LIM, Lin-11 Isl-1 Mec-3; PCI, Proteasome, COP9, Initiation factor-3; PTP, protein tyrosine phosphatase.
doi:10.1371/journal.pone.0049045.t001
Figure 1. Schematic representation of yeast two-hybrid high confidence hits involved in transcription. Individual prey fragment clones
and the resulting selected interaction domains (SIDs) reported to bind ALKBH4 are indicated above each protein; black lines, placenta library; orange
lines, fetal brain library; green lines, placenta library screened with ALKBH4H169A/D171A; red dashed lines, SIDs. Grey boxes indicate protein domains.
Proteins and domains are drawn to scale according to the InterPro (version 4.8) and PROSITE (release 20.68) databases [73,74].//indicates regions
omitted for simplicity. ZnF, C2H2 zinc finger; HD, homeodomain; YEATS, Yaf9 ENL AF9 Taf14 Sas5; TAZ, transcription adaptor putative zinc finger; BRD,
bromodomain; PHD plant homeodomain; HAT histone acetyl transferase; DBD, DNA binding domain. Bar, 100 aa.
doi:10.1371/journal.pone.0049045.g001
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dividual contribution of the two domains considered here can not
be determined from this experiment.
ALKBH4 Partly Co-localizes with the RNA Polymerase I
Complex
Being the site of ribosome biogenesis, the nucleolus also
comprises the process of ribosomal RNA (rRNA) synthesis. Our
observations of ALKBH4 co-localizing in nucleolar foci with all
three transcription-associated proteins examined made us specu-
late if ALKBH4 could potentially have a function in transcription
of ribosomal DNA (rDNA) genes. We therefore examined whether
ALKBH4 and ENL co-localize with the RNA polymerase I
subunit RPA43. Thus, HeLa cells were transiently co-transfected
with plasmids encoding ALKBH4-EYFP, ECFP-ENL and a Red
Fluorescent Protein (RFP)-fusion of RPA43 (RPA43-RFP). RPA43
was observed at the surroundings of the distinct nucleolar
ALKBH4/ENL foci with partially overlapping staining observed
(Figure S1, insert and nucleolus at the lower right). Partial co-
localization of ALKBH4 with ENL in nucleoplasmic and nucleolar
spots was detected, as mentioned above. Notably, we observed
a larger amount of ENL foci overlapping with RPA43 foci
compared to the overlap between ALKBH4 and RPA43. Hence,
these results suggest that ALKBH4 is not primarily involved in
nucleolar RNA polymerase I-dependent rDNA transcription.
Effects of ALKBH4 and ALKBH7 on Global Gene
Expression and DNA Methylation Patterns
We further considered the possibility that ALKBH4 may itself
be capable of modulating transcription. To investigate this, we
generated a stable HEK293 cell line in which the ALKBH4
encoding gene was introduced at a specific, transcriptionally
active, genomic locus, behind a tetracycline-inducible promoter,
thereby enabling controlled over-expression of ALKBH4. Ectopic
ALKBH4 expression was induced upon treatment with the
tetracycline analog doxycycline (DOX), and the resulting
ALKBH4 increase was verified on the mRNA and protein levels,
by qPCR and Western blotting, respectively (Figures 3A and B).
The global gene expression profiles of the ALKBH4 over-
expressing cell line and the non-induced, parental cell line were
subsequently compared in a microarray-based genome-wide
expression analysis. Surprisingly, very small effects on gene
expression were observed upon over-expression of ALKBH4.
Actually, none of the genes were up- or down-regulated above 2-
fold, and only 22 genes showed differential expression when the
fold change stringency was reduced to 1.35 (Figure 3C). A list of
differentially expressed genes (q-value ,5, fold change (FC)
.1.35) upon ALKBH4 over-expression is shown in Table 2.
Noteworthy, the absence of ALKBH4 itself among the up-regulated
genes in the over-expressing cell line is explained by annealing of
the probe to the untranslated region (UTR) of the gene (data not
shown). The low number of genes affected by ALKBH4 over-
expression indicates that ALKBH4 does not affect transcription at
the global level in the HEK293 cells.
Furthermore, to characterize the biological functions of the
genes affected by ectopic ALKBH4 expression, a gene ontology
(GO) analysis was performed using MetaCore GeneGo Pathways
Analysis software (GeneGo Inc.). However, the differentially
expressed genes were not enriched in any molecular pathway.
Several mammalian AlkB homologs have been shown to be
involved in DNA/RNA transactions, and these are basic proteins
with a high pI value, thus allowing binding to the negatively
charged nucleic acid backbone. In contrast, ALKBH1, ALKBH4
and ALKBH7 are acidic proteins, and it has been proposed that
they may be involved in demethylating histones or other proteins
(Sedgwick et al. 2007). Indeed, genetic ablation of ALKBH1 has
been shown to dysregulate a number of genes in the mouse
placenta [24], and we were therefore also interested in in-
vestigating the effects of ALKBH7 on gene regulation. Using the
same approach as for ALKBH4, we generated a stable HEK293
cell line with tetracycline-inducible over-expression of ALKBH7,
which was used to determine the effects of ectopic ALKBH7 levels
on gene expression. Considerably stronger effects were detected in
the case of ALKBH7, compared to ALKBH4. A total of 532
genes, excluding ALKBH7, were differentially expressed (q-value
,5, FC .2) between the parental and ALKBH7 over-expressing
cell lines. Of these, 197 genes were up-regulated and 335 genes
were down-regulated (Figure 3C). Notably, ALKBH7 over-
expression resulted in a higher number of down-regulated
compared to up-regulated genes and, moreover, the most down-
regulated genes were more strongly affected (3.8, FC ,5.4) than
the most up-regulated ones (2.9, FC ,3.4). The most up- or
down-regulated genes are listed in Table 3.
In order to determine possible enrichment of ALKBH7 affected
genes in certain biological pathways, we further performed a GO
analysis similar to that of ALKBH4. Twelve GO categories were
determined to be significantly overrepresented (false discovery rate
(FDR) ,0.05) among the differentially expressed genes
(Figure 3D). The pathway mostly enriched with ALKBH7 affected
genes was ‘‘cell cycle and its regulation’’, in which 33 of 444 genes
displayed expression level alterations upon ectopic ALKBH7
expression. While the great majority of these (31 genes) showed
decreased expression, only two genes, RBX1 (RING-box protein 1)
and PRKAR1A (PKA-regulatory subunit 1A), were up-regulated.
ALKBH7 is annotated in the NCBI database as spermatogen-
esis-associated protein 11 (SPATA11) or spermatogenesis cell
proliferation-related protein. Interestingly, the results of our
GeneGo pathway analysis included ‘‘spermatogenesis’’ as a cate-
gory of enriched genes (Figure 3D). Herein, three genes (CREB1,
PRKAR1A and GNAS1) of a total of 22, belonging to the sub-
category ‘‘transcription – CREM signaling in testis’’, were
differentially expressed after ALKBH7 over-expression. Moreover,
among the top twenty up-regulated genes, three genes involved in
the process of meiotic recombination during gametogenesis were
identified: disrupted meiotic cDNA 1 (DMC1) [43], decreased sperm
survival 1 (DSS1) [44] and male-specific lethal 3-like 1 (MSL3L1) [45].
Thus, our results are consistent with an association of the ALKBH7
gene with spermatogenesis.
To complement the gene expression data, we also performed
microarray-based CpG methylation profiling in cells over-expres-
sing either ALKBH4 or ALKBH7, as well as in the respective non
over-expressing cells. In case of both proteins, the methylation
pattern remained strikingly constant upon over-expression
(r2 = 0.9975 and 0.9916 for ALKBH4 and ALKBH7, respectively.
Figure S2), thus excluding a role for ALKBH4 and ALKBH7 in
regulation of global CpG methylation.
Figure 2. Subcellular localization of ALKBH4 and its co-localization with transcription-associated proteins. (A) Subcellular localization
of ALKBH4-EYFP in HeLa cells. Co-expression of (B) ALKBH4-ECFP and AF9-EYFP, (C) ALKBH4-EYFP and ECFP-ENL, (D) ALKBH4-ECFP and EYFP-
ENLYEATS, (E) ALKBH4-ECFP and ENLC-EYFP and (F) ALKBH4-ECFP and EYFP-p300BP, as analyzed by confocal fluorescence microscopy. Insets are
enlargements of boxed areas.
doi:10.1371/journal.pone.0049045.g002
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In vivo H3K79 Methylation Levels are not Affected by
Ectopic ALKBH4 Expression
Regulation of transcription depends on dynamic chromatin
modifications, such as histone methylation, involving proteins with
either methyltransferase or demethylase activity. In contrast to the
situation for methylated lysine residues found at the flexible
histone tails, no demethylase has been found to reverse the
activating methyl mark at the lysine 79 (K79) residue in the
globular domain of H3, which in mammals is introduced by the
enzyme DOT1L. However, there are indications of the existence
of such enzyme activity [46,47], and a study in which treatment of
cells with 2-hydroxyglutarate (2HG), an inhibitor of Fe(II)/2OG-
dependent oxygenases, resulted in increased H3K79 dimethyl
levels has further suggested a member of this protein family to be
the enzyme responsible for H3K79 demethylation [48]. Moreover,
ALKBH4 has previously been suggested to possess protein
demethylase activity [26], and our results imply a role for
ALKBH4 in chromatin regulation. Since we found ALKBH4 to
interact with the DOT1L-associated proteins AF9 and ENL, we
speculated that ALKBH4 could potentially function as a demethy-
lase with specificity for methylated H3K79. In order to address
this issue, we isolated histones from the DOX-inducible ALKBH4
over-expressing HEK293 cell line before and after DOX
induction, as well as from a similarly generated cell line possessing
the ability of stable, inducible over-expression of an enzymatically
inactive ALKBH4 mutant (ALKBH4H169A/D171A). Subsequently,
the methylation status at the H3K79 position in the histones was
determined by Western blotting. However, we did not observe any
effect of ectopic ALKBH4 expression on the methylation status of
histone H3K79, as similar levels of mono-, di- and trimethylated
H3K79 were detected in the non-overexpressing cells as well as in
those over-expressing ALKBH4H169A/D171A (Figure 4). This
suggests that ALKBH4, if involved in demethylation of this
histone residue, might be restricted to certain, presently unknown,
conditions to be functional.
Discussion
In the present work, we report that proteins involved in
transcription were strongly over-represented among interactants of
the human oxygenase ALKBH4 identified by Y2H screens, while
no convincing partners were detected for the related ALKBH7
protein. Interestingly, the regions of these transcription-associated
interactants that was responsible for interaction with ALKBH4, in
Figure 3. Effects of ectopic expression of ALKBH4 or ALKBH7 on global gene expression. (A) Quantitative RT-PCR analysis of relative
ALKBH4 levels in HEK293 cells stably transfected with a construct for DOX-inducible over-expression of ALKBH4-FLAG, either treated with DOX (2 mg/
ml) or untreated. Results are presented as mean fold change of three independent replicates normalized to b-actin6 S.D. (B) Ectopic ALKBH4 protein
levels in DOX-induced and non-induced cells, as determined by Western blot analysis. Ectopic ALKBH4 was detected using an antibody against the
FLAG-tag introduced at the C-terminus of ALKBH4. GAPDH expression levels are included as loading control. (C) Microarray analysis of gene
expression in cells over-expressing either ALKBH4 or ALKBH7 vs. non-overexpressing cells. The number of genes whose expression is altered at least
2.0-fold (ALKBH7) or 1.35-fold (ALKBH4) is indicated (D) MetaCore (GeneGo Inc.) analysis of molecular pathways significantly (False discovery rate
(FDR) ,0.05) enriched with genes affected by ectopic ALKBH7 expression. DOX, doxycycline.
doi:10.1371/journal.pone.0049045.g003
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all cases encompassed domains which are involved in interaction
with DNA and chromatin, and for some of these interactants we
observed a co-localization with ALKBH4 in distinct foci in the
nucleus. We also performed a global analysis of gene expression
and CpG methylation changes induced by ectopic over-expression
of ALKBH4 and ALKBH7. While we saw rather small effects of
ALKBH4 on both expression and methylation, larger effects on
gene expression were observed in the case of ALKBH7.
Protein Partners Suggest a Role for ALKBH4 in Gene
Regulation
Our identification of the transcriptional co-activator p300 as an
ALKBH4 partner is indicative of a gene regulatory role of
ALKBH4. The region of p300 mediating the ALKBH4-in-
teraction covered both the bromodomain and plant homeodomain
(PHD) of this protein. Both domains represent motifs found in
chromatin modification effector proteins, thus functioning in
recruitment of remodeling-complexes to chromatin. While bro-
modomains recognize acetylated histones [49], the zinc-coordi-
nating PHD finger is generally involved in binding methylated or
unmodified histone H3 [50]. However, PHD fingers are often
found close to bromo- or chromodomains [51], and several reports
have shown a combinatorial function of the two domains [52,53].
The function of the p300 PHD finger is still to be elucidated,
although it has been reported to be required, together with the
bromodomain, for in vitro recognition of acetylated nucleosomes
[41]. Notably, the histone acetyl transferase CBP, which is highly
similar to p300, was not identified as an ALKBH4 interaction
partner in the yeast two-hybrid screen. However, p300 HAT
activity does not, in contrast to that of CBP, depend on its PHD
finger, implying non-redundant functions for these co-activators
[54].
Further supporting an involvement of ALKBH4 in gene
regulation, we also detected the homologs AF9 and ENL as
interacting partners. In addition to a hydrophobic, transcription-
associated C-terminus both proteins contain an N-terminal
YEATS domain [37], which we here found to mediate the
ALKBH4 interaction. The YEATS domain has been named after
proteins that carry such a domain (Yaf9, ENL, AF9, Taf14 and
Sas5), and many of these proteins are components in transcrip-
tional or chromatin-modifying complexes. The specific function of
YEATS has not yet been determined, but several findings indicate
a role in chromatin binding. The interaction between ENL and
histones H1 and H3 has previously been demonstrated to be
mediated through YEATS [55], and recently, AF9/ENL YEATS
was found to be the module responsible for recruitment of the
super elongation complex (SEC) to chromatin and the elongating
Polymerase II [56]. Moreover, as a result of the first three-
dimensional YEATS structure, this domain was recently suggested
to provide an additional reader module of chromatin, analogous to
the bromodomain and PHD finger [57,58], with the Yaf9 YEATS
domain suggested to potentially bind acetylated lysine-residues in
histones [57].
The interactions of ALKBH4 with the transcription factors
HSF4 and ATBF1 were found to involve domains with the ability
of DNA binding, these being the DNA binding domain (DBD) of
Table 2. Differentially expressed genes (q-value ,5, fold change .1.35) identified in ALKBH4 over-expressing cells compared to
parental non over-expressing cells.
Gene Description Fold Change
Up-regulated1 HSPA1B Heat shock 70kDa protein 1B 1.63
INSIG1 Insulin induced gene 1, transcript variant 2 1.43
LAMA5 Laminin, alpha 5 1.43
FAM38A Family with sequence similarity 38, member A 1.39
HSPA8 Heat shock 70kDa protein 8, transcript variant 1 1.38
LOC642031 Hypothetical protein LOC642031 1.38
FASN Fatty acid synthase 1.36
LOC23117 KIAA0220-like protein, transcript variant 16 1.35
INTS1 Integrator complex subunit 1 1.35
SEC16A SEC16 homolog A 1.35
Down-regulated DDIT4 DNA-damage-inducible transcript 4 21.55
LGALS1 Lectin, galactoside-binding, soluble, 1 21.50
LETMD1 LETM1 domain containing 1, transcript variant 1 21.48
LOC653994 Similar to Eukaryotic translation initiation factor 4H, transcript variant 2 21.48
SLC3A2 Solute carrier family 3, member 2, transcript variant 6 21.45
CTH Cystathionase (cystathionine gamma-lyase), transcript variant 1 21.43
TSC22D3 TSC22 domain family, member 3, transcript variant 2 21.43
MCM7 Minichromosome maintenance complex component 7, transcript variant 1 21.38
DDIT3 DNA-damage-inducible transcript 3 21.37
STC2 Stanniocalcin 2 21.37
SNX5 Sorting nexin 5, transcript variant 1 21.37
RASSF1 Ras association (RalGDS/AF-6) domain family member 1, transcript
variant C
21.36
1The ALKBH4 probe was not detected due to annealing to the UTR of the gene. Sorted by fold change.
doi:10.1371/journal.pone.0049045.t002
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HSF4 and two of the multiple C2H2-type zinc fingers of ATBF1.
The versatile C2H2 motif, which is frequently found in gene
regulators, has been demonstrated to mediate interactions with
proteins as well as both DNA and RNA (reviewed in [59]).
Previously, two of the ATBF1 zinc fingers have been reported to
bind protein [60].
Interestingly, three of the transcription-associated ALKBH4
partners, AF9, ENL and p300, have all been reported to be fused
to the histone methyltransferase MLL in mixed-lineage leukemia
(MLL) [37,61,62], which is characterized by abberant H3K79
dimethylation profiles [63]. While the ALKBH4 interacting
YEATS domain of AF9/ENL is not present in the fusion proteins
MLL-AF9 and MLL-ENL [37], the less frequent MLL-p300
fusions, which are thought to promote leukemogenesis through
aberrant histone acetylation rather than methylation [61,64],
retain the ALKBH4 interacting p300 region.
Molecular Function of ALKBH4
Although the present work suggests that ALKBH4 may be
involved in processes such as chromatin regulation and transcrip-
tion, its molecular function remains an enigma. Interestingly, two
of the herein identified ALKBH4 interacting proteins with
associations to chromatin regulation and transcription, AF9 and
ENL, also interact with DOT1L, the enzyme responsible for
methylation of lysine 79 at histone H3 (H3K79). While no
demethylase with specificity for this residue has been reported so
far, there are indications of such activity [46,47]. The responsible
enzyme has been suggested to be an Fe(II)/2OG dioxygenase, as
elevated H3K79 dimethyl levels has been observed as a result of
Fe(II)/2OG dioxygenase inhibition [48]. Intriguingly, plants lack
both H3K79 methylation and DOT1L orthologs [65], as well as
ALKBH4. Thus, ALKBH4 could be imagined to function as an
H3K79 demethylase. Consequently, we investigated whether
ectopic ALKBH4 expression affected the cellular H3K79 meth-
ylation status in HEK293 cells. However, we did not detect
alterations in the levels of neither mono-, di- nor trimethylated
H3K79 after ALKBH4 over-expression. Related Fe(II)/2OG
dioxygenase activities include JumonjiC (JmjC) protein mediated
histone demethylation [2], structural and gene regulatory protein
hydroxylation by prolyl-4-hydroxylase (P4H) and prolyl hydrox-
ylase domain containing (PHD) 1–3, respectively [5,66], as well as
epigenetic DNA hydroxylation by the TET enzyme family, which
was recently reported to convert 5-methylcytosine (5-meC) to 5-
hydroxymethylcytosine (5-hmC) [1]. Previously, the low pI-value
of ALKBH4 has suggested this enzyme to possess a protein, rather
than a nucleic acid substrate [26], and, consistently, no activity
towards the classical AlkB substrates 1-meA and 3-meC has been
detected [67]. Furthermore, we previously showed uncoupled
decarboxylase activity for ALKBH4, indicating that this protein is
a bona fide Fe(II)/2OG dioxygenase [30].Thus, a demethylase or
hydroxylase activity targeting proteins or, less likely, nucleic acids,
could be envisioned for ALKBH4.
Association of Genes Affected by ALKBH7 Over-
expression with DNA Recombination
The previous annotation of ALKBH7 being associated with
spermatogenesis is consistent with the data presented here, as
functional annotation analysis revealed spermatogenesis as one of
the biological pathways enriched with genes differentially
expressed upon ectopic ALKBH7 expression. Meiotic recombi-
nation is one of the central events occurring during spermatogen-
esis, and, consistently, three genes with functions in meiotic
recombination were found among the twenty most up-regulated
ones. This, in combination with the over-representation of genes
related to cell cycle regulation and the DNA damage response
among the differentially expressed genes, may indicate a possible
role for ALKBH7 in the process of homologous recombination
repair (HRR) of double strand breaks (DSBs) introduced by DNA
Table 3. The genes most differentially expressed in either direction identified in ALKBH7 over-expressing cells compared to
parental non over-expressing cells.
Gene Description Fold Change
Up-regulated ALKBH7 AlkB, alkylation repair homolog 7 13.54
MSL3L1 Male-specific lethal 3-like 1, transcript variant 1 3.41
LOC643287 Similar to prothymosin alpha, transcript variant 1 (LOC643287) 2.97
RPL21 Ribosomal protein L21 2.96
NBPF20 Neuroblastoma breakpoint family, member 20 2.95
PEBP1 Phosphatidylethanolamine binding protein 1 2.90
GNL3L Guanine nucleotide binding protein-like 3 (nucleolar)-like 2.89
SHFM1 Split hand/foot malformation (ectrodactyly) type 1 2.85
Down-regulated LOC650215 Similar to Exportin-T (tRNA exportin) -5.42
PKMYT1 Protein kinase, membrane associated tyrosine/threonine 1, transcript variant 2 -4.53
GDF15 Growth differentiation factor 15 -4.43
LOC643031 Similar to NADH dehydrogenase subunit 5 -4.06
MAZ MYC-associated zinc finger protein, transcript variant 2 -3.93
CCT7 Chaperonin containing TCP1, subunit 7 (eta), transcript variant 1 -3.91
NGRN Neugrin, neurite outgrowth associated (NGRN), transcript variant 1 -3.87
LOC727761 Similar to Deoxythymidylate kinase, transcript variant 4 -3.86
CNBP CCHC-type zinc finger, nucleic acid binding protein -3.85
MORF4L2 Mortality factor 4 like 2 -3.80
doi:10.1371/journal.pone.0049045.t003
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damage as well as in homologous recombination (HR) during
meiosis, and maybe also mitosis. Thus, we speculate whether
ALKBH7 might function in general regulation of cellular
responses to repair of DNA double strand breaks by homologous
recombination.
Conclusions
In the current work we have identified several partners of the
ALKBH4 protein and an analysis of these partners suggests some
processes, such as chromatin regulation and transcription, in
which ALKBH4 may play an important part. Moreover, through
analysis of global gene expression changes in response to ALKBH7
over-expression, we observed enrichment of differentially ex-
pressed genes in processes like cell cycle and spermatogenesis,
supporting the previous annotation of ALKBH7 as a cell pro-
liferation and spermatogenesis-related protein. Obviously, more
rigorous studies are required to firmly establish the possible role of
ALKBH4 and ALKBH7 in these processes, but the present study
may represent a useful starting point.
Materials and Methods
Yeast Two-hybrid Assays
Two libraries (Human Placenta RP4 and Human Fetal Brain
RP1) were screened using full-length human ALKBH4 as bait (N-
LexA-ALKBH4-C fusion). Additionally, an enzymatically inactive
ALKBH4 mutant (ALKBH4H169A/D171A; mutagenesis described
in [30]) was used as bait to screen the human placenta RP4 library.
All screens and subsequent data analysis were performed by
Hybrigenics.
Plasmid Construction
For generation of ALKBH4-ECFP and -EYFP fusion con-
structs, human ALKBH4 cDNA was subcloned between the
EcoRI and BamHI sites of the pECFP-N1 and pEYFP-N1 vectors
(Clontech), respectively. To prepare the AF9-EYFP plasmid, AF9
(IMAGE-5298142) was PCR amplified (primers AF9-fwd and AF9-
rev, primer sequences can be found in Table S1) and cloned into
the XhoI/KpnI site of pEYFP-N1. pSXG-p300BP [41] was used
for amplification of the bromodomain and PHD finger encoding
fragment of p300 (primers p300BP-fwd and p300BP-rev), which was
cloned into the XhoI/EcoRI site of pEYFP-C1 (Clontech),
generating the EYFP-p300BP plasmid. To ensure nuclear access
of the EYFP-p300BP fusion protein, a sequence encoding a nuclear
localization signal (NLS) was subsequently PCR amplified from
pCMV-nucEGFP-BP-HA (kindly provided by R. Aasland) using
primers NLS-fwd and NLS-rev, and cloned into the EcoRI/KpnI
site of the EYFP-p300BP plasmid. The ENL open reading frame
was amplified from pBSIISK+ENL (kindly provided by R. Slany),
using primers ENL-fwd and ENL-rev, and cloned into the XhoI/
KpnI site of pEYFP-N1 (Clontech), generating the ENL-EYFP
construct. A fragment encoding the N-terminus of ENL (aa 1–141)
was amplified (primers ENL-fwd and YEATS-rev) and cloned into
the XhoI/KpnI site of pEYFP-C1, resulting in the EYFP-
ENLYEATS construct, encoding a YEATS domain fusion. The
XhoI/KpnI site was also used for cloning of the ENLC-EYFP
fusion construct (primers ENLC-fwd and ENL-rev), in which the
YEATS domain encoding part was deleted (aa 142–559).
For generation of inducible, stable cell lines expressing either
ALKBH4, ALKBH4H169A/D171A or ALKBH7 (described below),
the respective cDNAs were amplified (primer sequences can be
found in Table S1) and cloned between the BamHI and EcoRV
sites of pcDNA5/FRT/TO (Invitrogen), resulting in the plasmids
pcDNA5/FRT/TO-ALKBH4, pcDNA5/FRT/TO-AL-
KBH4H169A/D171A and pcDNA5/FRT/TO-ALKBH7. A FLAG
epitope tag was introduced in the reverse primers for simple
detection of the proteins. All constructs were verified by DNA
sequencing.
In vivo Acetylation Assay
The assay was performed essentially as previously described in
[68]. Briefly, plasmids encoding FLAG-ALKBH4 (pCIneoB-
3xFLAG-ALKBH4) and p300 (pCMVb-p300) were transiently
co-transfected into HCT116 cells using FuGene6 (Roche)
according to the manufacturer’s specifications. Empty vectors
were used as controls. Twenty four hours after transfection, the
cells were treated with the deacetylase inhibitor Trichostatin A
(TSA, 2 mM) for 30 minutes or left untreated. Total cell extracts
were prepared in lysis buffer (50 mM HEPES pH 7.9, 420 mM
NaCl, 0.5% NP-40, 1 mM phenylmethylsulfonyl fluoride (PMSF),
0.5 mM dithiothreitol (DTT) and Complete protease inhibitor
cocktail (Roche)). Subsequently, 1–2 mg total cell extract and 2–
5 mg anti-FLAG antibody (Sigma F3165) was used for immuno-
precipitation of FLAG-ALKBH4. The resulting precipitates were
analyzed by Western blotting using an anti-acetyl-lysine antibody
(Upstate 06-933) followed by reprobing of the membrane with the
anti-FLAG antibody.
GST Pull-down Assay
The TNT T7 Quick for PCR DNA system (Promega) was used
according to the manufacturer’s descriptions to produce in vitro
transcribed/translated [35S]-methionine labelled ALKBH4 in
Figure 4. Ectopic ALKBH4 expression does not change H3K79
methylation levels in vivo. As analyzed by Western blotting, all three
methylation states (mono- di- and tri-methylation) of the H3K79 residue
remained similar in histones purified from stable HEK293 transfectants
after doxycycline-dependent over-expression of either ALKBH4 or an
enzymatically inactive mutant (ALKBH4H169A/D171A), compared to the
equivalent, non-induced cells. Signal intensities of bands corresponding
to methylated histones were quantified using ImageJ [69], and
normalized to the total histone H3 load, but no effect of ALKBH4
overexpression was detected (not shown).
doi:10.1371/journal.pone.0049045.g004
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presence of Redivue L-[35S]-methionine (GE Healthcare). To
minimize production of truncated protein products due to partly
degraded mRNA, 10–15 mg RibonucleaseA (Sigma) was added to
the reaction mixtures subsequent to translation and further
incubated at room temperature for 10 minutes. GST fusions of
ENL and p300BP were separately expressed in E. coli, immobilized
on Glutathione Sepharose resin (GE Healthcare) and washed with
interaction buffer (50 mM Tris-HCl pH 8.5, 12 mM NaCl,
0.1 mM ZnAc, 150 mM KCl, 2 mM MgCl2, 10 mM 2-mercap-
toethanol, 0.1% Triton X-100). In vitro translation reaction
mixture (5–10 ml) was added to the immobilized GST-fusion
proteins, which were incubated with gentle agitation for 30 min at
room temperature. Reactions were subsequently subjected to four
washes with interaction buffer and one wash with 50 mM Tris-
HCl pH 8.0 prior to elution with GST-elution buffer (50 mM
Tris-HCl pH 8.0, 15 mM reduced glutathione, 0.1 mM ZnAc).
Similarly, reciprocal pull-downs using GST-ALKBH4 and [35S]-
labelled p300BP (alternatively full-length p300) were also per-
formed. GST-only was included as control. Eluted proteins were
analyzed by SDS-PAGE followed by phosphor imaging using LE
Storage Phosphor Screens (GE Healthcare) and an exposure time
of 1–4 days. Signals were visualized in a TyphoonTM 9400 scanner
(GE Healthcare).
Co-immunoprecipitation
Plasmids encoding HA-tagged versions of ENL, AF9 or p300BP,
or the empty vector (pCMV-script, Stratagene), were separately
transfected into Flp-In-293-ALKBH4 cells (described below) using
FuGene6 (Roche) according to the manufacturer’s descriptions.
Cells were treated with 2 mg/ml DOX to induce expression of
FLAG-tagged ALKBH or left untreated. After 18–24 hours, the
cells were harvested in phosphate-buffered saline (PBS) and
washed once in PBS before 5–66106 cells were subjected to
crosslinking in PBS with 0.125–0.25% formaldehyde for 20
minutes at 37uC. The crosslinking reaction was stopped by the
addition of 0.15 M glycine followed by incubation on ice for 3
minutes and subsequently at room temperature for 2 minutes.
To prepare cell extracts, the cells were washed twice with PBS
and resuspended in 3 volumes (,200 ml) of Buffer I (20 mM
HEPES pH 7.9, 1.5 mM MgCl2, 100 mM KCl, 0.2 mM EDTA,
20% glycerol, 0.5% NP-40, 1 mM DTT, Complete protease
inhibitor cocktail (Roche)) containing 2 ml Omnicleave Endonu-
clease (200 U/ml Epicentre Technologies) followed by sonication,
addition of DNase/RNase cocktail (200 U/ml Omnicleave Endo-
nuclease, 250 U/ml Benzonase (Novagen), 30 mg/ml RNase
(Sigma-Aldrich), 10 U/ml DNase (Roche), 100–300 U/mg micro-
coccal nuclease (Sigma-Aldrich)), incubation with gentle agitation
for 1 hour at room temperature and subsequently over night at
4uC. The extracts were cleared by centrifugation at 14,0006g at
4uC for 10 minutes.
Immunoprecipitation was performed by pre-incubating the cell
extracts with 2–5 mg anti-FLAG antibody (Sigma F3165) in 5 ml
Buffer II (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 100 mM KCl,
0.2 mM EDTA, 10% glycerol, 1 mM DTT, Complete protease
inhibitor cocktail (Roche)) at room temperature for 1 hour.
Subsequently, 50 ml 10% Sepharose rec-Protein G (Invitrogen)
was added and the samples were incubated with gentle agitation at
4uC for 1 hour. After extensive washing with Buffer II the
immunocomplexes were resuspended in Laemmli buffer. Cross-
links were reversed by incubating the samples at 70uC for 10
minutes followed by addition of 0.1 M DTT and further
incubation at 95uC for 30 minutes. Immunocomplexes were
analyzed by SDS-PAGE and Western blotting using an anti-HA
antibody (Abcam Ab9110), and membranes were reprobed with
the anti-FLAG antibody.
Confocal Imaging
Live HeLa S3 cells (ATCC) were examined 16–24 h after
transient transfection (using FuGene 6 or FuGene HD (Roche)
according to the manufacturer’s recommendations) of the ECFP/
EYFP/RFP fusion constructs. The fluorescent images were
acquired using a Zeiss LSM 510 Meta laser scanning microscope
equipped with a Plan-Apochromate 636/1.4 oil immersion
objective. The images were acquired in the growth medium of
the cell, with the stage heated to 37uC, using the Zeiss LSM 510
software. ECFP was excited at l=458 nm and detected at
l=470–500 nm and EYFP was excited at l=514 nm and
detected at l=530–600 nm. The thickness of the slice was
1 mm. All images were acquired with consecutive scans to avoid
bleed through. No image processing, except contrast and intensity
adjustments, were performed.
Establishment and Maintenance of Stable, Inducible Cell
Lines
Inducible cell lines for stable over-expression of FLAG epitope-
tagged versions of ALKBH4, ALKBH4H169/D171A and ALKBH7,
respectively, were generated using the Flp-InTM T-RExTM System
(Invitrogen) and the Flp-InTM T-RExTM-293 host cell line
(Invitrogen, R780-07), according to the manufacturer’s specifica-
tions. This system ensures isogenic cDNA expression from a single
transcriptionally active genomic locus. Briefly, pcDNA5/FRT/
TO-ALKBH4, pcDNA5/FRT/TO- ALKBH4H169/D171A and
pcDNA5/FRT/TO-ALKBH7 (described above) were indepen-
dently co-transfected with the Flp recombinase-encoding
pOGG44 vector into the Flp-InTM T-RExTM-293 host cell line,
using FuGene6 transfection agent (Roche). Selection of transfec-
tants was performed in presence of 200 mg/ml Hygromycin B
(Clontech). Single colonies conferring hygromycin B resistance
and zeocin sensitivity were expanded and treated with doxycycline
(Clontech). Total cell extracts were prepared using RIPA lysis
buffer (Santa Cruz), according to standard methods, and screened
for ALKBH over-expression by Western blotting (described
below). Stable transfectants were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) (Lonza) supplemented with
10% tetracycline-free fetal bovine serum (FBS) (Clontech), 100 U/
ml penicillin (Lonza), 100 U/ml streptomycin (Lonza), 2 mM L-
glutamine (Lonza), 15 mg/ml blasticidin-S (Invitrogen) and
200 mg/ml hygromycin B. Ectopic ALKBH expression was
induced by addition of 2 mg/ml doxycycline (DOX) to the
medium. For microarray analysis, transgene expression was
induced at a cell confluence level of approximately 50%. Cells
were harvested 48 hours after induction. All samples were
prepared in triplicates.
Histone Purification
Histones were purified from Flp-InTM-293 cells (Invitrogen)
containing a stable, doxycycline-inducible integration expressing
FLAG-ALKBH4 or FLAG-ALKBH4H169A/D171A (described
above), either treated with doxycycline or untreated, using the
Histone purification mini kit (Active Motif) according to the
manufacturer’s specifications. Briefly, cells were lysed in Extrac-
tion Buffer at 4uC for 1 hour. Cleared lysates were neutralized and
loaded onto pre-equilibrated spin columns which were washed
prior to histone elution. Purified histones were subsequently
concentrated by perchloric acid precipitation.
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Antibodies and Western Blot Analysis
Total cell extracts or histones were subjected to separation by
SDS-PAGE (NuPAGEH SDS-PAGE Gel System, Invitrogen) and
transferred onto Invitrolon PVDF membranes (Invitrogen).
Membranes were subjected to blocking with 5% dry milk in
PBS with 0.1% Tween-20 (PBS-T) for 1 hour. After incubation
with primary antibody diluted in PBS-T with 5% dry milk for 1
hour, the membranes were washed three times with PBS-T,
incubated with secondary antibody diluted in PBS-T with 2,5%
dry milk for 1 hour and subjected to three additional washes with
PBS-T. Primary antibodies used were anti-FLAG (Sigma F3165),
anti-HA (Abcam Ab9110), anti-GAPDH (Applied Biosystems
AM4300), anti-acetyl-lysine (Upstate 06-933) anti-H3K79me1
(Abcam ab2886), anti-H3K79me2 (Abcam ab3594), anti-
H3K79me3 (Abcam ab2621) and anti-H3 (Abcam ab1791). While
the anti-H3K79me1 and anti-H3K79me3 antibodies were specific
towards mono- and trimethylated H3K79, respectively, anti-
H3K79me2 antibody specificity towards dimethylated H3K79 was
ensured by pre-incubating the antibody with two H3 derived
peptides containing either mono- (Abcam ab4555) or trimethy-
lated (Abcam ab4557) H3K79 (1 mg/ml of each) for 30 min at RT
before incubation with the membrane, thereby blocking mono-
and trimethyl reactive sites (data not shown). Anti-FLAG and anti-
GAPDH antibodies were used in combination with an alkaline
phosphatase-conjugated secondary antibody and the Amersham
ECF detection system (GE Healthcare). Fluorescence signal
detection was performed in a Typhoon scanner 9400 (GE
Healthcare). The remaining antibodies were used in combination
with a horseradish peroxidase-conjugated secondary antibody and
the SuperSignal West Dura kit (Thermo Scientific). Chemilumi-
nescence signals were visualized on a Kodak Image Station 4000R
Pro instrument (Carestream Health). Densitometry was performed
using the ImageJ software [69].
RNA and Genomic DNA Isolation
Total RNA and genomic DNA were isolated from cell lines
over-expressing ALKBH4 or ALKBH7 or the equivalent non-
induced cell lines. For RNA isolation, TRIzol (Invitrogen) was
used according to the manufacturer’s descriptions. The RNA was
subsequently subjected to a clean-up step using the RNeasy Mini
Kit (Qiagen) according to the RNA Cleanup procedure in the
supplied manual. Genomic DNA was isolated using the QIAamp
DNA Mini Kit (Qiagen) according to the manufacturer’s protocol.
Quantitative PCR Analysis
SuperScript II Reverse Transcriptase (Invitrogen) was used to
synthesize cDNA, using oligo(dT)12218 primers (Invitrogen) and
5 mg of total RNA. cDNA synthesis was performed according to
the manufacturer’s specifications, except that the incubation step
prior to addition of the SuperScript II RT was omitted.
Quantitative PCR (qPCR) was performed in 20 ml reactions using
SYBR Green master mix (Qiagen), 4 ml cDNA (diluted 1:16), and
10 pmol ALKBH4-specific primers (ALKBH4-qPCR-fwd and
ALKBH4-qPCR-rev, primer sequences can be found in Table S1).
Reactions were performed on a LightCycler 1.5 instrument
(Roche). LightCycler software 3.5.3 (Roche) was used for data
analysis and quantification was performed using the DCT method
[70] with b-actin as endogenous reference (primers beta-actin-fwd
and beta-actin-rev). All experiments were performed in triplicates.
Microarrays and Data Analysis
mRNA expression and CpG methylation profiling was
performed by the Helse Sør-Øst/University of Oslo Genomics
Core Facility using the Illumina HumanWG-6 v3 Expression
BeadChip and Illumina Infinium HumanMethylation27 Bead-
Chip, respectively, according to the manufacturer’s protocols.
Data extraction and initial quality control of the bead summary
raw data were performed using GenomeStudio v2011.1 from
Illumina and the Gene Expression and Methylation module
v1.9.0. The data was annotated using the HumanWG-
6_V3_0_R3_11282955_A and HumanMethyla-
tion27_270596_v1.2 annotation files from Illumina. Unnorma-
lized bead intensities were exported into a tab delimited text file
and imported into J-express Pro (v. 2.7) for further downstream
analysis [71]. Bead intensities were quantile normalized, and rank
product analysis was performed to identify gene expression
changes [72]. A significant threshold of q-value ,5 and a fold-
change larger than 1.35 for ALKBH4 or 2 for ALKBH7 was used
to identify differentially expressed genes. Differentially expressed
genes were further analyzed in MetaCore (GeneGo) to identify
functional enrichment.
CpG methylation data was analyzed using the GenomeStudio
Methylation Module, where avgBeta (average ratio of signal from
methylated probe relative to the sum of both methylated and
unmethylated probes) was calculated and used for comparisons
within sample groups.
The mRNA expression and CpG methylation datasets have
been deposited in the GEO data repository (www.ncbi.nlm.nih.
gov/geo/, accession number GSE39135).
Supporting Information
Figure S1 Partial co-localization of ALKBH4 and ENL
with RNA Polymerase I subunit RPA43 in nucleolar
speckles. Co-expression of ALKBH4-EYFP with ECFP-ENL
and RPA43-RFP in HeLa cells, as analyzed by confocal
fluorescence microscopy. Insets are enlargements of boxed areas.
(PDF)
Figure S2 Effects of ALKBH4 and ALKBH7 over-expres-
sion on the global DNA methylation pattern. CpG
methylation profiles were analyzed in stably transfected
HEK293 cells before vs. after doxycycline induced over-expression
of ALKBH4 (left panel) or ALKBH7 (right panel), using the
Illumina Infinium HumanMethylation27 BeadChip. DOX, doxy-
cycline.
(PDF)
Table S1 Primer sequences.
(PDF)
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